2025
SJR Q1
JCR Q2 · 4,4
157 matched articles
SCIE
Journal detail
Endocrine Practice
- Publisher
- Elsevier B.V.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1530891X19342403
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,345
- Quartile Q1
- H-Index 111
- Cites/doc 3,45
- Docs (3y) 494
- Cites (3y) 1.830
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,4
- 5Y JIF 4,4
- JCI 0,87
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,345 | 4,4 | 4,4 | 0,87 | Q2 | 111 |
| 2024 | Q1 | Q1 | 1,182 | 4,6 | 4,1 | 0,94 | Q1 | 107 |
| 2023 | Q1 | Q2 | 1,208 | 3,7 | 3,6 | 0,97 | Q2 | 107 |
| 2022 | Q1 | Q2 | 1,003 | 4,2 | 3,8 | 0,87 | Q2 | 107 |
| 2021 | Q2 | Q3 | 0,821 | 3,7 | 4,1 | 0,77 | Q2 | 107 |
| 2020 | Q2 | Q3 | 0,93 | 3,4 | 4,2 | 0,87 | Q2 | 107 |
| 2019 | Q1 | Q2 | 1,452 | 3,9 | 3,3 | 1,06 | Q1 | 107 |
| 2018 | — | Q1 | — | 4,1 | 3 | 1,07 | Q1 | — |
| 2017 | Q1 | Q2 | 1,224 | 3,8 | 3 | 0,83 | Q2 | 107 |
| 2016 | Q1 | Q3 | 0,996 | 2,3 | 2,6 | — | — | 107 |
| 2015 | Q1 | Q3 | 0,903 | 2,1 | 2,3 | — | — | 107 |
| 2014 | Q1 | Q2 | 1,056 | 2,8 | 2,8 | — | — | 107 |
| 2013 | Q2 | Q3 | 0,841 | 2,6 | — | — | — | 107 |
| 2012 | Q1 | Q3 | 1,056 | 2,3 | — | — | — | 107 |
| 2011 | Q1 | Q2 | 0,892 | 2,5 | — | — | — | 107 |
| 2010 | Q1 | — | 0,825 | — | — | — | — | 107 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 59/198 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 43/193 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 62/186 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 51/145 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 83/146 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 90/146 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 43/143 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 34/145 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 42/142 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 92/138 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 96/133 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 64/128 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 65/124 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 69/122 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 60/122 |